Sign up
Pharma Capital

Celica Biomedical looks for hospital partnership to facilitate use of its therapies

Celica Biomedical Director Dr. Robert Zorec spoke with Proactive Investors at the 11th Annual BioTech Showcase in San Francisco.

Celica Biomedical develops new technologies for research into physiological processes at the level of a single cell. The Slovenia based company also develops new therapies for neurological applications and advanced cell-based medical products to be used in personalized medicine.


View full CELIC profile View Profile
View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.